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Jean-Pierre Becquemin, MD, FRCS, Créteil, France
Objective: This study compared early-term and midterm results of endovascular repair (EVAR) of juxtarenal or pararenal
aortic aneurysms (PAAs) using fenestrated stent grafting (f-EVAR) and the chimney grafting (c-EVAR) technique.
Methods: Consecutive patients with PAAs who underwent f-EVAR using commercially available devices and c-EVAR in a
tertiary vascular center from January 2006 to April 2013 were evaluated, including a retrospective scrutiny and update of
a prospectively maintained database, calculation and comparison of perioperative mortality and morbidity, overall sur-
vival, reintervention-free rate, branch event-free rate, reconstructed vessel patency, and collection of data about intra-
operative events, perioperative complications and reinterventions, and midterm sac behavior.
Results: During the study period, 80 patients (72 men) underwent f-EVAR and 38 (34 men) underwent c-EVAR. All
f-EVAR patients were operated on electively, whereas six c-EVAR patients (15.8%; P [ .002) were operated on in an
emergent setting. The preoperative PAA diameter was signiﬁcantly smaller in the f-EVAR group than in the c-EVAR
group (58.6 6 8.6 mm vs 65.9 6 15.3 mm; P[ .003). The mean number of reconstructed vessels per patient was 2.4 6
0.7 (median, two) for the f-EVAR group and 1.6 6 0.7 (median, one) for the c-EVAR group (P < .0001). The f-EVAR
and c-EVAR groups did not differ in 30-day mortality (6.3% vs 7.9%; P [ .71) or in moderate to severe complications
(27.5% vs 39.5%; P[ 1.0). Median follow-up duration was 14 months, (range, 0-88 months) in the f-EVAR group and
12 months (range, 0-48 months) in the c-EVAR group. After 2 years, estimated survival rates (77.3% vs 71.8%),
reintervention-free rates (71.4% vs 72.0%), reconstructed vessel event-free rates (90.5% vs 84.1%), and primary patency of
reconstructed vessel rates (97.1% vs 87.6%) were not statistically different. During follow-up, sac shrinkage ($5 mm) was
observed in 43.4% of f-EVAR patients and in 30.6% of c-EVAR patients (no statistical difference).
Conclusions: In this limited retrospective series, short-term and midterm results of f-EVAR and c-EVAR were not statis-
tically different. c-EVAR could be an attractive option for patients not suitable for f-EVAR. (J Vasc Surg 2014;60:31-9.)Until recently, the gold standard for treatment of a jux-
tarenal or pararenal aortic aneurysm (PAA) was open surgi-
cal repair (OSR).1-3 During the last 15 years, purely
endovascular abdominal aortic aneurysm (AAA) repair
(EVAR) approaches have been developed to reduce post-
operative mortality and morbidity. The feasibility of fenes-
trated endografting (f-EVAR) for the treatment of complex
AAAs is now widely recognized, with several large series
conﬁrming satisfactory early-term and midterm results.4-6
However, the applicability of the technique is limited by
strict anatomic requirements, high costs, and lengthy
manufacturing lead-times.
Greenberg et al7 ﬁrst described the use of parallel renal
stents combined with an aortic stent graft in patients with athe Department of Vascular Surgery, Henri Mondor Hospital, Uni-
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then, the chimney (c-EVAR) graft technique has been advo-
cated as a possible endovascular alternative to OSR of
complex AAAs. One advantage of this technique is its imme-
diate availability. However, uncertainties about long-term
patency of reconstructed visceral vessels and the risk of type
Ia endoleak (EL) through the “gutters” located between
the aorta, the stents, and the stent graft remain a concern.
To date, only a few limited retrospective series have
compared f-EVAR and c-EVAR.8-10 The objective of this
retrospective study was to compare the results of f-EVAR
and c-EVAR for PAAs within a single institution.
METHODS
Patients and inclusion criteria. The study included
all consecutive patients treated by f-EVAR or c-EVAR
with commercially available stent grafts for PAA, from
January 2006 to April 2013, in a tertiary vascular unit
(Henri Mondor Hospital, Créteil, France). PAAs included
short-necked infrarenal, juxtarenal, and PAAs considered
unsuitable for conventional EVAR. Exclusion criteria
were bailout chimney graft procedures for unexpected
covering of one or both renal arteries during standard
EVAR, f-EVAR with a physician-modiﬁed stent graft, and
branched or combined (ie, fenestrated and branched or
fenestrated and chimney) stent grafts. Patients with failure31
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construction of visceral branch(es), by bailout chimney
technique were included in the f-EVAR cohort.
In our institution, OSR or EVAR is scrutinized for all
patients with PAAs during a weekly multidisciplinary
meeting of vascular surgeons, interventional radiologists,
and anesthesiologists. All patients were deemed at high
risk for OSR. The choice between f-EVAR and c-EVAR
was determined by clinical and anatomic characteristics.
In the current series, indications for f-EVAR met manufac-
turer’s inclusion and exclusion criteria. Patients with an
aortic angle of $45 were excluded. Most c-EVAR proce-
dures were performed for a PAA associated with at least
one of the following conditions:
d Anatomical contraindications to f-EVAR, including
any or all of small or tortuous iliac arteries, severe iliac
occlusive disease, proximal migration, type Ia EL after
previous EVAR, or an angulated aorta;
d A patient with an aneurysm that was considered life-
threatening (diameter >60 mm, rapidly expanding or
painful aneurysm) and who could not wait for a fenes-
trated stent graft to be manufactured.
In the c-EVAR group, we limited reconstructions to
one or two target vessels if possible. Patients who required
reconstruction of more than two target vessels were consid-
ered to be treated by another parallel technique, such as
sandwich technique.
Preoperative assessment and device sizing. All pa-
tients underwent a high-resolution computed tomogra-
phy (CT) scan preoperatively and before discharge.
Procedure planning and device sizing were deﬁned using
Aquarius WS (TeraRecon Inc, Mateo, Calif), a dedicated
three-dimensional vascular imaging workstation, with
centerline luminal reconstructions.
For f-EVAR cases, device designs suggested by the
implanting physicians complied with the manufacturer’s
guidelines and were systematically reviewed and approved
by the planning center of the relevant device manufacturer.
The sealing zone was deﬁned as parallel neck of 15 mm in
length, whether or not it included the oriﬁce of a visceral
artery; thus, we used the aorta at the level of the fenestra-
tion as a sealing zone if that segment was healthy.
To be eligible for c-EVAR, patients had to present a
satisfactory (>15 mm in length) proximal landing zone
of healthy aorta below the proximal edge of the main de-
vice. When visceral branches were covered, we recon-
structed them by chimney technique.
Deﬁnitions. The proximal extent of the PAA was clas-
siﬁed according to American College of Cardiology/Amer-
ican Heart Association 2005 practice guidelines for the
management of patients with peripheral arterial disease.11
Preoperative coronary artery disease was deﬁned as an
abnormal result on a stress test or coronary angiogram
and a history of myocardial infarction or open or percuta-
neous coronary artery revascularization. Congestive heartfailure was clinically deﬁned by past hospital admission
for acute exacerbation or an ejection fraction of <30%.
Arrhythmia was identiﬁed on electrocardiogram upon
admission. Chronic obstructive pulmonary disease was
identiﬁed on pulmonary function studies or under active
medication. Hypertension, dyslipidemia, and diabetes
were identiﬁed in patients undergoing active medical treat-
ment or diet modiﬁcation. Cerebrovascular disease was
deﬁned on a history of stroke, transient ischemic attack,
or carotid intervention. Previous aortic surgery included
OSR or endovascular aortic surgery.
Preoperative renal insufﬁciency was deﬁned as serum
creatinine values >160 mmol/L. Renal impairment was
deﬁned by a 50% increase in the creatinine value compared
with baseline levels.
The deﬁnition of a target vessel was any vessel recon-
structed using a bare-metal stent or a covered stent or ves-
sel(s) failing to be reconstructed despite planning. Scallops
in f-EVAR were not considered indicative of target vessels.
Target vessels reconstructed by a bailout chimney graft
technique in the f-EVAR group were considered as a failure
of revascularization and excluded from target vessel anal-
ysis. Target vessel patency was deﬁned as absence of target
vessels stenosis or occlusion requiring reintervention dur-
ing follow-up. Reconstructed vessel events included target
vessel occlusion, any reintervention needed, or aneurysm
sac growth induced by a branch-related EL (type III in
f-EVAR or type I gutter in c-EVAR).
Device implantation. Technical aspects of f-EVAR
using commercially available devices have been detailed in
previous reports.5,12,13 We have previously reported our
technique of chimney stent grafting.14,15 In short, when
only one target artery was reconstructed, cannulation and
covered stent deployment were performed through a left
axillary or a left brachial approach. At the beginning of our
experience, when two or three target arteries were treated,
we used two axillary/brachial arteries approaches to ensure
access to at least two target arteries until the ﬁnal angio-
gram. As we gained experience, we simpliﬁed the procedure
and used a single left axillary approach: we inserted covered
stents dedicated to target vessels, one after the other, before
deploying the aortic stent graft. Over time, we also used
balloon-expandable covered stents (BECSs; Advanta V12;
Atrium Medical, Hudson, NH) instead of self-expandable
covered stents (Fluency; Bard, Tempe, Ariz). Most often,
covered stents were reinforced by self-expandable stents
(SESs) or BECSs. In some casesdmainly at the beginning
of our experiencedwe used bare stents.
We collected operative data, including total operation
time, ﬂuoroscopy time, amount of contrast, type and
conﬁguration of the fenestrated device, devices for the
chimney graft technique, and reconstructed vessels.
Follow-up protocol. Oral antiplatelet and statin med-
ications were administered to all patients before the proce-
dure and lifelong thereafter. In the absence of speciﬁc
contraindications (creatinine clearance <30 mL/min, se-
vere iodine contrast allergy), a contrast-enhanced CT
Table I. Clinical and anatomic data
Variablesa
f-EVAR
(n ¼ 80)
c-EVAR
(n ¼ 38) P
Male 72 (90.0) 34 (89.5) 1.0
Age, years 73.9 6 9.5 74.3 6 8.7 .84
Coronary artery disease 44 (55.0) 15 (39.5) .17
Congestive heart failure 1 (1.3) 4 (10.5) .037
Arrhythmia 9 (11.3) 10 (26.3) .058
COPD 26 (32.5) 11 (28.9) .83
Hypertension 56 (70.0) 30 (78.9) .38
Dyslipidemia 41 (51.3) 22 (57.9) .56
Diabetes 14 (17.5) 10 (26.3) .33
Cerebrovascular disease 13 (16.3) 4 (10.5) .58
Peripheral artery disease 9 (11.3) 11 (28.9) .033
Renal insufﬁciency 12 (15.0) 9 (23.7) .81
Hemodialysis 0 1 (2.6) .32
Prior aortic surgery 4 (5.0) 9 (23.7) .004
Current smoking 27 (33.8) 5 (13.2) .026
ASA classiﬁcation .003
2 28 (35.0) 3 (7.9)
3 46 (57.5) 29 (76.3)
4 6 (7.5) 6 (15.8)
Aneurysm diameter, mm 58.6 6 8.6 65.9 6 15.3 .003
Extent of aneurysm <.001
Juxtarenal 56 (70.0) 37 (97.4)
Pararenal 24 (30.0) 1 (2.6)
Infrarenal neck length, mm 1.5 6 2.5 2.3 6 3.1 .16
ASA, American Society of Anesthesiologists; c-EVAR, chimney endovas-
cular aneurysm repair; COPD, chronic obstructive pulmonary disease;
f-EVAR, fenestrated endovascular aneurysm repair.
aContinuous data are shown as mean 6 standard deviation and categoric
data as number (%).
Table II. Indications of chimney endovascular aneurysm
repair (c-EVAR)
Variable Patient, No. (%)
Large (>60 mm) or rapidly expanding aneurysm 10 (26.3)
Type Ia EL after EVAR 7 (18.4)
Unfavorable anatomy for f-EVAR 15 (39.5)
Rupture 4 (10.5)
Pain 2 (5.3)
Total 38
EL, Endoleak; f-EVAR, fenestrated endovascular aneurysm repair.
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6 and 12 months, and annually thereafter. In case of EL on
postoperative CT scan, an additional 3-month CT scan was
prescribed. At each time point, all patients and each of the
scans were reviewed by senior surgeons.
Study description and objectives. This was a retro-
spective study comparing f-EVAR and c-EVAR for PAAs.
The following data were collected in a prospectively main-
tained database. Comparison between the two groups
included (1) preoperative clinical and anatomic data; (2)
intraoperative data; (3) postoperative data, including 30-
day mortality, moderate to severe complications, and
early reinterventions; and (4) midterm follow-up data,
comprising estimated overall survival, freedom from rein-
tervention, freedom from reconstructed vessel event as
deﬁned in the deﬁnition paragraph, and primary patency
rates of reconstructed vessels.
Statistics. For comparison, categoric variables were
analyzed using the c2 test or the Fisher exact test when
appropriate. Continuous variables were analyzed using Stu-
dent t-test or Mann-Whitney test when appropriate. Time-
to-event was analyzed using Kaplan-Meier curves for
overall survival, freedom from reintervention, freedom
from reconstructed vessel event, and for individual recon-
structed vessels primary patency rates. All P values were
two sided, and P values of <.05 were considered statisti-
cally signiﬁcant. Statistical analyses were done using EZRsoftware (Saitama Medical Center, Jichi Medical Univer-
sity, Saitama, Japan), which is a graphic user interface
for R 3.0.0 software (The R Foundation for Statistical
Computing, Vienna, Austria).RESULTS
Patient population. The ﬁrst f-EVAR case was per-
formed in January 2006 and the ﬁrst c-EVAR case in
June 2009. During the study period, 80 patients (72
men) underwent f-EVAR and 38 patients (34 men) under-
went c-EVAR for a PAA. Demographic and anatomic data
are detailed in Table I. The c-EVAR group had greater
comorbidities and a higher American Society of Anesthe-
siologists Physical Status Classiﬁcation grade. Four patients
with prior aortic surgery (one case was prior EVAR) un-
derwent f-EVAR.
f-EVAR is the ﬁrst choice in our institution, and c-
EVAR was chosen only when f-EVAR could not be
done. However, more c-EVARs were performed in patients
with previous aortic surgery when the use of a fenestrated
stent graft was thought contraindicated due to short
main graft length or to small diameter of the graft limb.
The proximal extent of the aneurysm was more pro-
nounced in the f-EVAR group than in the c-EVAR group
(P < .001). Indications of c-EVAR are listed in Table II.
All f-EVAR patients were operated on electively. In
contrast, six c-EVAR patients (15.8%) were operated on
in an emergent scenario.
Aortic stent grafts and reconstructed branch ves-
sels. Stent grafts in the f-EVAR group (n ¼ 80) were
Zenith fenestrated (Cook Medical, Bloomington, Ind) in
64 (80.0%), Ventana (Endologix, Irvine, Calif) in nine
(11%), and Anaconda (Vascutek, Terumo, Inchinnan,
United Kingdom) in seven (9%). There was no speciﬁc cri-
terion for choosing which commercial device to use.
Choice was made according to the surgeon’s preference.
Fenestrated stent graft conﬁgurations were 1 fenestra-
tion and 2 scallops in 3; 2 fenestrations in 41: 9 alone,
24 with 1 scallop, and 8 with 2 scallops; 3 fenestrations
in 31: 8 alone and 23 with 1 scallop; and 4 fenestrations
in 5. In f-EVAR cases, all target vessels were bridged
with BECSs (Advanta V12).
The most frequently used stent design in the c-EVAR
group was a BECS reinforced by a SES (32 of 60
Table III. A, Reconstructed vesselsa
Vessel f-EVAR, No.b c-EVAR, No.
Celiac artery 4 0
SMA 36 10
Renal arteries
Right 75 24
Left 77 26
Accessory 2 0
Total 194 60
c-EVAR, Chimney endovascular aneurysm repair; f-EVAR, fenestrated
endovascular aneurysm repair; SMA, superior mesenteric artery.
aScallop was not counted as reconstructed vessel.
bTwo arteries reconstructed by bailout chimney technique in the f-EVAR
group were excluded.
Table III. B, Number of vessels reconstructed
Reconstructed
vessels, No. f-EVAR, No. c-EVAR, No. P
1 3 20 <.0001
2 44 14
3 29 4
4 4 0
Average per patienta 2.4 6 0.7 1.6 6 0.7
aData shown as mean 6 standard deviation.
Table IV. Intraoperative technical events
Variable f-EVAR, No. (%) c-EVAR, No. (%) P
Malposition
Main body 5 (6.3) 1 (2.6) .66
Limb 2 (2.5) 0 1.0
Cannulation failure 5 (6.3) 1 (2.6) .66
Target vessel
Injury or dissection 3 (3.8) 2 (5.3) .66
Embolism 2 (2.5) 0 1.0
Limb or access problem 6 (7.5) 1 (2.6) .43
Type I or III EL 7 (8.8) 2 (5.3) .72
Total 21 (26.3) 6 (15.8) .25
c-EVAR, Chimney endovascular aneurysm repair; EL, endoleak; f-EVAR,
fenestrated endovascular aneurysm repair.
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vessels during c-EVAR.
The number of reconstructed vessels per patient was
signiﬁcantly higher in the f-EVAR group (P < .0001;
Table III). In only four patients in the c-EVAR group
were three vessels reconstructed, which included the supe-
rior mesenteric artery (SMA). The remaining six patients
with a reconstructed SMA were two with one kidney,
one with dialysis, and two after kidney transplantation,
and the remaining patient was unknown.
Intraoperative events. Intraoperative events are listed
in Table IV. In the f-EVAR group, we failed to cannulate
ﬁve target vessels, among which one SMA and one renal
artery were ﬁnally revascularized using a bailout chimney
technique. All failures were caused by malposition of the
main body of the stent graft. We could not ﬁnd the tech-
nical reason of one failure in c-EVAR group. Although all
events but target vessel injury or dissection were more
frequent in the f-EVAR group, the difference was not
signiﬁcant.
Other operative data. In the f-EVAR vs c-EVAR
groups, respectively, total operative time was 191 6
99 min vs 183 6 69 min, ﬂuoroscopy time was 43 6
34 min vs 43 6 43 min, and the amount of contrast was
136 6 84 mL vs 139 6 102 mL. The difference between
the two groups was not signiﬁcant.
Postoperative mortality and morbidity. The 30-day
mortality rate was 6.3% (ﬁve of 80) in the f-EVAR group vs
7.9% (three of 38) in the c-EVAR group (P ¼ .71). The
in-hospital mortality rate was 10.0% (eight of 80) in thef-EVAR group vs 5.3% (two of 39) in the c-EVAR group
(P ¼ .50). One patient was discharged on postoperative
day 12 and returned to the hospital on postoperative day
23 due to SMA stent occlusion. He underwent iliome-
senteric bypass and colectomy but ultimately died on
postoperative day 25. Of the nine patients who presented
with bowel ischemia, two in the f-EVAR group and one in
the c-EVAR presented with small bowel ischemia, and the
remaining were left colon ischemias.
Postoperative moderate to severe complications are
summarized in Table V. The two groups had statistically
similar rates of moderate to severe complications.
Midterm results. Median follow-up duration was
14 months (range, 0-88 months) in the f-EVAR group and
12 months (range, 0-48 months) in the c-EVAR group.
Estimated overall survival rates were similar in both groups
(Fig 1). Among patients who survived the operation, 10
died during the follow-up period in the f-EVAR cohort and
four in the c-EVAR cohort. One death in the f-EVAR
group was due to stent graft infection at 45 months,
whereas the remaining nine deaths were not related to the
aneurysm. The four late deaths in the c-EVAR group were
not related to the aneurysm. There was no statistically
signiﬁcant difference in freedom from reintervention,
freedom from reconstructed vessel event, and cumulative
reconstructed vessel patency rates between the two groups
(Figs 2-4).
Persistent renal impairment after intervention occurred
in 12 of 80 (15.0%) f-EVAR patients, and in ﬁve of 38
(13.2%) c-EVAR patients (P ¼ 1.0).
At the last follow-up, 15 ELs (3 type Ia, 1 type III, and
11 type II) were found in the f-EVAR group (20.8%; eight
unknown cases were excluded), and four ELs (two type Ia
and two type II) were found in the c-EVAR group (12.1%;
5 unknown cases were excluded; P ¼ .41). During the
follow-up period, sac shrinkage ($5 mm) and sac growth
occurred in 33 of 72 (45.8%) and 3 of 72 (4.2%) of
f-EVAR patients and in 11 of 35 (31.4%; P ¼ .21) and 2
of 35 (5.7%; P ¼ .66) c-EVAR patients. Cause of sac
growth was type Ia EL in one f-EVAR patient and type
II EL in one c-EVAR patient. The cause remained uniden-
tiﬁed in the three other patients.
Table V. Early postoperative mortality and morbidity
Variable
f-EVAR c-EVAR
PEvents, No. Patients, No. (%) Events, No. Patients, No. (%)
Death
30-day 5 (6.3) 3 (7.9) .71
In-hospital 8 (10.0) 2 (5.3) .50
Complications 37 (46.3) 19 (50.0) .84
$Grade 2 or moderate 22 (27.5) 10 (26.3) 1.0
Cardiac 4 4 (5.0) 0 0 .30
Acute coronary syndrome 2 0
Arrhythmia 2 0
Respiratory 1 1 (1.3) 1 1 (2.6) .54
Acute respiratory distress syndrome 1 1
Pulmonary embolism 1 1 (1.3) 0 0 1.0
Gastrointestinal 9 8 (10.0) 3 3 (7.9) 1.0
Bowel ischemia 7 2
Upper gastrointestinal perforation 1 0
Bowel paralysis 1 0
Colitis (not ischemic) 0 1
Renal 15 13 (16.3) 10 8 (21.1) .61
Renal impairment (>50% basal creatinine) 10 7
Dialysis 2 1
Kidney infarction 3 2
Neurologic 4 4 (5.0) 2 2 (5.3) 1.0
Transient spinal cord ischemia 3 0
Cerebral infarction 1 2
Vascular 10 10 (12.5) 4 4 (10.5) 1.0
Target vessel 6 1
Access vessel 3 3
Access site false aneurysm 1 0
Other 14 11 (13.8) 12 11 (28.9) .075
Wound problem 6 3
Access site hematoma 0 5
Graft infection 1 0
Sepsis 4 0
Intra-abdominal or retroperitoneal hemorrhage 0 3
Compartment (reperfusion) syndrome 1 0
Trash foot 1 0
Urinary tract infection 1 1
c-EVAR, Chimney endovascular aneurysm repair; f-EVAR, fenestrated endovascular aneurysm repair.
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detailed in Table VI. There were 34 reinterventions (of
which 16 were #30 days after intervention) in the f-EVAR
group and 10 reinterventions (of which six were #30 days)
in the c-EVAR group. Eight branch-related reinterventions
were required in the f-EVAR group and three in the
c-EVAR group.
DISCUSSION
In this study, we compared early-term and midterm
results of f-EVAR and c-EVAR and found no statistical dif-
ference in mortality, morbidity, and sac behavior.
Since the ﬁrst report of f-EVAR in 1996,16 data from
national registries and from expert centers have provided
encouraging short-term and midterm results.5,6 f-EVAR
is now increasingly used in Europe, Australia, and the
United States. Several reports have emphasized its superi-
ority over OSR in perioperative mortality and morbidity.17
However, f-EVAR remains technically challenging, asshown by our own data, and manufacturing lead-time is
still a problem. Until off-the-shelf devices are available,
fenestrated stent grafts cannot be applied to patients with
a large, symptomatic, or ruptured aneurysm. Cost is also
an issue. Indeed, f-EVAR costs approximately two to three
times as much as standard EVAR.
Parallel techniques, such as chimney or snorkel tech-
niques, have emerged as endovascular alternatives for treat-
ing complex AAAs. Preliminary data showed encouraging
results, comparable to those of f-EVAR, one advantage of
this technique being that it is immediately available and re-
quires basic endovascular tools.18
Both f-EVAR and c-EVAR present a risk of EL
inherent to the technique. A fenestration is a reinforced
hole created in the wall of the stent graft. There is no inter-
component overlap between a fenestration and the target
vessel stent, only a reinforced fabric edge.19 On the other
hand, the interference of the chimney grafts on the circum-
ferential apposition of the stent graft makes it impossible to
Fig 1. Kaplan-Meier curve shows overall survival in patients
undergoing endovascular aneurysm repair (EVAR) with chimney
(c-EVAR) or fenestrated (f-EVAR) techniques.
Fig 2. Kaplan-Meier curve shows reintervention-free survival in
patients undergoing endovascular aneurysm repair (EVAR) with
chimney (c-EVAR) or fenestrated (f-EVAR) techniques.
Fig 3. Kaplan-Meier curve shows reconstructed vessel event-free
rate in patients undergoing endovascular aneurysm repair (EVAR)
with chimney (c-EVAR) or fenestrated (f-EVAR) techniques.
Fig 4. Kaplan-Meier curve shows for primary patency rate of
reconstructed vessels in patients undergoing endovascular aneu-
rysm repair (EVAR) with chimney (c-EVAR) or fenestrated
(f-EVAR) techniques.
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nel, or “gutter,” is therefore inevitable.18 This gutter itself
is a type I EL that can lead to a catastrophic result. Besides,
branch stability is affected by eventual migration of the
aortic stent graft in f-EVAR, potential compression of the
chimney stent by the aortic stent graft, and other various
factors such as material fatigue or intimal hyperplasia.
The advantage of one technique over the other is unclear
due to the scarcity of reports comparing both tech-
niques.8-10 Although two of these reports were meta-analyses, they showed no statistical difference between
the two endovascular procedures.
The aim of this study was to improve decision making
between f-EVAR and c-EVAR for complex aortic aneu-
rysms. Some patients are unﬁt not only for OSR but also
for f-EVAR. In addition, some technically difﬁcult cases
may not be safely treated by f-EVAR. For example, predict-
ing fenestration positioning with sufﬁcient accuracy is difﬁ-
cult in a patient with acute aortic angulation. Cannulation
Table VI. Early and late re-interventions after fenestrated endovascular aneurysm repair (f-EVAR) and chimney
endovascular aneurysm repair (c-EVAR)
Variable
Early (#30 days) Late (>30 days)
Procedure, No. Patients, No. (%) Procedure, No. Patients. No. (%)
f-EVAR
Target vessel occlusion or stenosis 3 3 (3.8) 2 2 (2.5)
Limb occlusion or stenosis 2 2 (2.5) 1 1 (1.3)
Main body occlusion 0 0 1 1 (1.3)
Access complication 2 2 (2.5) 0 0
EL
Ia 0 0 1 1 (1.3)
Ib 0 0 1 1 (1.3)
II 0 0 8 5 (6.3)
III 2 2 (2.5) 0 0
Mesenteric ischemia 3 3 (3.8) 1 1 (1.3)
Infection
Stent graft 0 0 1 1 (1.3)
Other graft 1 1 (1.3) 0 0
Wound 1 1 (1.3) 0 0
Others
Bleeding/hematoma 2 2 (2.5) 0 0
Compartment syndrome 1 1 (1.3) 0 0
Total 17 16 (20) 16 8 (10)
c-EVAR
Target vessel occlusion or stenosis 1 1 (2.6) 1 1 (2.6)
Limb occlusion or stenosis 1 1 (2.6) 0 0
Access complication 2 2 (5.3) 1 1 (2.6)
EL
Ia 0 0 1 1 (2.6)
II 0 0 1 1 (2.6)
Others
Bleeding/hematoma 2 2 (5.3) 0 0
Total 6 6 (15.8) 4 4 (10.5)
EL, Endoleak.
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steep angulation, or calciﬁcation. There is not enough in-
formation indicating the most appropriate technique for
those cases. Some experts might choose f-EVAR because
of its theoretical superiority, and some might prefer
c-EVAR to avoid potential technical difﬁculties. In our
institution, most c-EVAR patients had large or rapidly
expanding aneurysms presenting a risk of rupture, emer-
gent ruptured, or symptomatic aneurysms unable to with-
stand the 2 months needed for device manufacturing, and
others had a morphologic contraindication for f-EVAR.
Preoperative health conditions were more severe in the
c-EVAR group than in the f-EVAR group.
In this study, all early-term and midterm results
showed no signiﬁcant difference between the two groups
despite (1) larger aneurysms, (2) emergent settings, (3)
contraindications for f-EVAR, and (4) higher American So-
ciety of Anesthesiologists classiﬁcations in the c-EVAR
group. To compare midterm branch durability of f-EVAR
and c-EVAR, we assessed the freedom from reconstructed
vessel event rate, including branch occlusion, the need for
any reintervention, and the aneurysm sac growth induced
by reconstructed vessel-related EL, but found no statisti-
cally signiﬁcant difference.Issues related to renal impairment are worth
mentioning. In the current study, 12 patients (including
ﬁve requiring hemodialysis initiation) in the f-EVAR group
and ﬁve patients (four hemodialysis initiation) in the c-
EVAR group presented with signiﬁcantly deteriorated renal
function. Renal artery occlusion is not the only cause of
renal function impairment: it may also be induced by the
amount of contrast, by intraoperative manipulations of
renal arteries, by cholesterol emboli, and by repeated
contrast-enhanced follow-up CT scans. However, there
was no signiﬁcant difference between groups. Thus, c-
EVAR could be an appealing alternative to f-EVAR in cases
predicted as technically difﬁcult.
There are limitations to the data presented in our se-
ries. Although major outcome variables did not differ
signiﬁcantly between the groups, there could certainly be
a type II statistical error because the number is still much
too small to make deﬁnitive statements.
Although both techniques provided similar results, the
study duration was limited to only 1 year, and further
observation might lead to different results.
This was an observational and not a randomized study,
and the two groups were not strictly comparable. Fewer
vessels were reconstructed in the c-EVAR group than in
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of aneurysms in the c-EVAR group was lower than in the
f-EVAR group.
Donas et al20 reported the combined results of two in-
stitutions (Münster and Zurich): one of the two teams had
the therapeutic algorithm of performing c-EVAR only in
cases of one or two branch reconstructions, similar to our
policy; however, the other team reported good results
with more than two chimney grafts.20 Whereas devices
used for target vessel reconstruction in f-EVAR were all
BECSs, with or without SESs, a variety of devices were
used for c-EVAR. Current literature gives no consensus or
recommendation about the most appropriate type of chim-
ney stent. Donas et al20 showed excellent results for both
balloon-expandable and self-expandable covered stents.20
The current study did not enable us to assess how this
choice affects gutter EL or branch patency due to the small
number of ELs and to the heterogeneity of techniques.
The mortality rates of both groups were higher than
those previously reported. All patients were high risk and
were denied OSR because of poor health condition. In
addition, causes of death were mostly due to mesenteric
embolism. The major causes were mural thrombus in the
thoracic aorta, which was fragmented by catheters and
endovascular maneuvers. We need to know what degree
of shaggy aortas would cause the distal embolism and
develop preoperative medications to reduce those cata-
strophic complications.
This study analyzes a 7-year experience. During that
period, the endovascular devices available for complex an-
eurysms have signiﬁcantly evolved. All devices used in early
cases of f-EVAR were custom-made Cook devices; howev-
er, not only off-the-shelf or custom-made devices from
other manufacturers but also homemade fenestrated stent
grafts in urgent setting were recently used. Nine Ventana
fenestrated grafts were included in this study. We know
that the company halted the trial of this new device and
is currently revising the graft concept due to renal compli-
cations. However, our cases were uneventful, and we have
not seen any later problem so far. In addition, we started
performing c-EVAR later than f-EVAR; since then, our
technical skills might have improved.
CONCLUSIONS
In our experience with complex EVAR, we report
similar results when using fenestrated or chimney endog-
rafts. c-EVAR may be an appealing and efﬁcient alternative,
not only in emergent settings but also in elective cases
where f-EVAR is predicted to be technically difﬁcult or is
contraindicated. Further follow-up is needed to assess
midterm to long-term results.
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